-
Be the first to like this
Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy.
Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our Privacy Policy and User Agreement for details.
Published on
The full report can be found here https://goo.gl/hshRvl
Wearables will change the execution and economics of drug R&D, expand the definition of “therapy,” and transform patients’ roles in healthcare.
Wearable technologies have the potential to transform medicine and the delivery of healthcare more significantly than any other component of the digital revolution – or indeed than many other scientific advances. By offering new, richer, and more nuanced sources of real-time data directly from patients, wearables can enable a greater understanding of disease and the factors that influence its course, both at the individual level and collectively. Wearables will transform how clinical trials are recruited and run, and which kinds of endpoints are measured. They will also change the economics of R&D, allowing faster recruitment, more reliable data collection, and shorter trial times.
For pharma, wearables provide not just an opportunity to reduce R&D costs, but also to improve outcomes and enhance relationships with patients, providers, and payers. They also bring new kinds of partners and competitors, and require a shift in mindset: to accept that future winners will not be those with the best molecule, but those who most effectively marry their scientific innovation with the appropriate technological innovation to ensure the best results.
The full report can be found here https://goo.gl/hshRvl
Be the first to like this
Login to see the comments